These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33898880)

  • 21. β-Adrenergic signaling stimulates osteoclastogenesis via reactive oxygen species.
    Kondo H; Takeuchi S; Togari A
    Am J Physiol Endocrinol Metab; 2013 Mar; 304(5):E507-15. PubMed ID: 23169789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RANKL induces Bach1 nuclear import and attenuates Nrf2-mediated antioxidant enzymes, thereby augmenting intracellular reactive oxygen species signaling and osteoclastogenesis in mice.
    Kanzaki H; Shinohara F; Itohiya K; Yamaguchi Y; Katsumata Y; Matsuzawa M; Fukaya S; Miyamoto Y; Wada S; Nakamura Y
    FASEB J; 2017 Feb; 31(2):781-792. PubMed ID: 27836987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of osteocytes in the in vitro and in vivo β-tricalcium phosphate-stimulated osteogenesis.
    Chen Z; Wu C; Yuen J; Klein T; Crawford R; Xiao Y
    J Biomed Mater Res A; 2014 Aug; 102(8):2813-23. PubMed ID: 24115533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo.
    Sakai E; Aoki Y; Yoshimatsu M; Nishishita K; Iwatake M; Fukuma Y; Okamoto K; Tanaka T; Tsukuba T
    Phytomedicine; 2016 Jul; 23(8):828-37. PubMed ID: 27288918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kirenol inhibits RANKL-induced osteoclastogenesis and prevents ovariectomized-induced osteoporosis via suppressing the Ca
    Zou B; Zheng J; Deng W; Tan Y; Jie L; Qu Y; Yang Q; Ke M; Ding Z; Chen Y; Yu Q; Li X
    Phytomedicine; 2021 Jan; 80():153377. PubMed ID: 33126167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities.
    Liu Y; Wang C; Wang G; Sun Y; Deng Z; Chen L; Chen K; Tickner J; Kenny J; Song D; Zhang Q; Wang H; Chen Z; Zhou C; He W; Xu J
    Theranostics; 2019; 9(16):4648-4662. PubMed ID: 31367247
    [No Abstract]   [Full Text] [Related]  

  • 27. Cordycepin Prevents Bone Loss through Inhibiting Osteoclastogenesis by Scavenging ROS Generation.
    Dou C; Cao Z; Ding N; Hou T; Luo F; Kang F; Yang X; Jiang H; Xie Z; Hu M; Xu J; Dong S
    Nutrients; 2016 Apr; 8(4):231. PubMed ID: 27104563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IGFBP7 acts as a negative regulator of RANKL-induced osteoclastogenesis and oestrogen deficiency-induced bone loss.
    Ye C; Hou W; Chen M; Lu J; Chen E; Tang L; Hang K; Ding Q; Li Y; Zhang W; He R
    Cell Prolif; 2020 Feb; 53(2):e12752. PubMed ID: 31889368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss.
    Zhu M; Liu H; Sun K; Liu J; Mou Y; Qi D; Zhou C; Abudunaibi M; Tasiken B; Li J; Cheng H; Huang H
    Biomed Pharmacother; 2020 Mar; 123():109769. PubMed ID: 31846839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nrf2 activation attenuates both orthodontic tooth movement and relapse.
    Kanzaki H; Shinohara F; Itohiya-Kasuya K; Ishikawa M; Nakamura Y
    J Dent Res; 2015 Jun; 94(6):787-94. PubMed ID: 25795629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gelatin-Modified Calcium/Strontium Hydrogen Phosphates Stimulate Bone Regeneration in Osteoblast/Osteoclast Co-Culture and in Osteoporotic Rat Femur Defects-In Vitro to In Vivo Translation.
    Kruppke B; Ray S; Alt V; Rohnke M; Kern C; Kampschulte M; Heinemann C; Budak M; Adam J; Döhner N; Franz-Forsthoffer L; El Khassawna T; Heiss C; Hanke T; Thormann U
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33153127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Nrf2 activator RTA-408 attenuates osteoclastogenesis by inhibiting STING dependent NF-κb signaling.
    Sun X; Xie Z; Hu B; Zhang B; Ma Y; Pan X; Huang H; Wang J; Zhao X; Jie Z; Shi P; Chen Z
    Redox Biol; 2020 Jan; 28():101309. PubMed ID: 31487581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tea polysaccharide inhibits RANKL-induced osteoclastogenesis in RAW264.7 cells and ameliorates ovariectomy-induced osteoporosis in rats.
    Xu H; Yin D; Liu T; Chen F; Chen Y; Wang X; Sheng J
    Biomed Pharmacother; 2018 Jun; 102():539-548. PubMed ID: 29587240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low‑frequency pulsed electromagnetic field inhibits RANKL‑induced osteoclastic differentiation in RAW264.7 cells by scavenging reactive oxygen species.
    Pi Y; Liang H; Yu Q; Yin Y; Xu H; Lei Y; Han Z; Tian J
    Mol Med Rep; 2019 May; 19(5):4129-4136. PubMed ID: 30942408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of light-emitting diode irradiation on RANKL-induced osteoclastogenesis.
    Sohn H; Ko Y; Park M; Kim D; Moon YL; Jeong YJ; Lee H; Moon Y; Jeong BC; Kim O; Lim W
    Lasers Surg Med; 2015 Nov; 47(9):745-55. PubMed ID: 26391894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin modified strontium-doped β-tricalcium phosphate can accelerate the healing of femoral metaphyseal defects in ovariectomized rats.
    Tao ZS; Zhou WS; Xu HG; Yang M
    Biomed Pharmacother; 2020 Dec; 132():110911. PubMed ID: 33125972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Schisandrin A restrains osteoclastogenesis by inhibiting reactive oxygen species and activating Nrf2 signalling.
    Ni S; Qian Z; Yuan Y; Li D; Zhong Z; Ghorbani F; Zhang X; Zhang F; Zhang Z; Liu Z; Yu B
    Cell Prolif; 2020 Oct; 53(10):e12882. PubMed ID: 32871020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
    Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
    Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A bioactive poly(ether-ether-ketone) nanocomposite scaffold regulates osteoblast/osteoclast activity for the regeneration of osteoporotic bone.
    Zhao M; Chen G; Zhang S; Chen B; Wu Z; Zhang C
    J Mater Chem B; 2022 Nov; 10(42):8719-8732. PubMed ID: 36239238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.